Quantcast

Tag Archives: biopharmaceutical

GlycoMimetics-Pfizer accord pays off

GlycoMimetics Inc., of Gaithersburg, a biopharmaceutical company focused on discovering and developing drugs for human wound healing and tissue repair, said it has received a $15 million payment from Pfizer Inc., under a collaborative agreement between the two companies for the development of rivipansel, a treatment for painful episodic flare-ups of sickle cell disease.

Read More »

Baltimore-based Cerecor obtains depression drug rights

Cerecor Inc., of Baltimore, a biopharmaceutical company focused on developing and commercializing prescription drugs involving the human nervous system, said it has acquired from Merck & Co. the exclusive, worldwide rights to a drug called MK-0657, which it said has the potential to treat depression. Merck originally developed MK-0657 for treatment of Parkinson’s disease.

Read More »